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 Synapsins are phosphoproteins in the brain located on synaptic vesicles and 
involved with regulating neurotransmitter release. The synapsins regulate the amount of 
synaptic vesicles available for release of neurotransmitters into the synapse through 
exocytosis and recycling mechanisms. Synapsin is evolutionarily conserved among 
species, especially in the large central C-domain. In mice lacking synapsin, neurons 
rapidly run out of synaptic vesicles, indicating that synapsin plays a key role in neuronal 
transmission. Synapsin mutations have been found in families with genetic forms of 
epilepsy.  
Although the function of synapsin is unknown, it has been shown that the C-domain 
binds ATP. Experimental evidence indicates that the residue at position 373 has a key 
role in ATP binding. However, in Drosophila, there is a serine substituted for glutamic 
acid at this position. Therefore, synapsin may not bind ATP. The goal of this project is to 
study whether or not the Drosophila synapsin C-domain binds ATP.  Drosophila 
synapsin will be cloned and expressed as a GST fusion protein, purified, and analyzed 
with stop-flow techniques.  The results of these experiments will establish whether or not 
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 Synapsins are abundant phosphoproteins that are important in regulating the 
release of neurotransmitters from the synaptic vesicles (Hosaka).  The synapsins regulate 
the amount of synaptic vesicles available for release of neurotransmitters into the synapse 
through exocytosis and recycling mechanisms. This mechanism is important as it 
moderates the intensity of neuronal stimulation. Synapsin is evolutionarily conserved 
among species, especially in the large central C-domain (Baldelli). In mice lacking 
synapsin, neurons rapidly run out of synaptic vesicles. Synapsin mutations have been 
found in families with genetic forms of epilepsy.  
 The synapsin family consists of three homologous proteins which are each 
composed of common domains A, B, and C, with variable carboxy terminal domains.  
The C-domain is most evolutionarily conserved among vertebrate and invertebrate 
species.  The conservation of the homologues emphasizes the importance and 
appropriateness of using Drosophila synapsin to study binding activity.  Suggestions are 
that the residue at position 373 has a key role in ATP binding. Drosophila has a serine 
substituted for glutamic acid, therefore not suggested to bind ATP (Klagges).  In 
Drosophila and honeybees, the conserved glutamic acid residue at position 373 is a serine 
for synapsin I.  The glutamic acid residue is negatively charged, requiring a Ca2+ 
stabilization to bind with ATP. Lysine residues are positively charged, not requiring the 
Ca2+ stabilization. Serine, a neutral amino acid residue, has been suggested to neither 
require Ca2+ or ATP binding in the synapsin I C-domain of Drosophila. Thus, 




Figure 1. Serine Substitution for Glutamic Acid position 373 in 
Drosophila Synapsin 
 This figure shows the amino acid sequence of Drosophila synapsin 
in alignment with the three human synapsin isoforms. The marked 
positions indicate the residues of importance to this study. In mammalian 
synapsins, change from glutamic acid to serine eliminates ATP binding. 
The isoforms shown have either a positive or negative charge. Position 
373 in Drosophila is a serine, raising the question of whether ATP binds 
to Drosophila synapsin.  
 
Previous research has shown that synapsin mutations lead to epileptic symptoms 
in humans and impaired learning abilities in flies (Garcia). Mice with synapsin mutations 
have shown impaired learning as well (Baldelli). A nonsense mutation was found at 
position 356 of synapsin in families with epileptic symptoms, before the studied location 
of ATP binding in the C-domain (Garcia). With the relatively little that is known about 
synapsins, future research of synapsins will lead to advancements in academia and health 
implications caused by synapsin mutations (Klagges and Wallace). By understanding the 
binding of the synapsin C-domain, we can determine the regulation of synaptic vesicles 




Cloning and Transformation 
 Stock DNA was obtained from the Drosophila Genomics Resource Center 
(DGRC in Bloomington, IN) and eluted using their protocol for the Whatman FTA disc.  
The order stock came from RE44971 from Riken Embryo, stock 9299, with ampicillin 
resistance (received on 8/5/09) in the pFLC1 vector. To amplify the DNA, DH5α E. coli 
cells were transformed.  However, no clones were obtained. Stock DNA was obtained 
from the DGRC again in November, 2009, and the previously used protocol was 
followed.  The colonies were then transformed on LB + carbenicillin plates as suggested 
by the DGRC.  Bacteria containing the DNA constructs were obtained in this second 
attempt. 
 Transformed bacteria were inoculated in LB broth with ampicillin overnight. 
DNA was prepared using a Bio-Rad Quantum Prep Plasmid Miniprep Kit (Bio-Rad; 
Hercules, CA) according to the manufacturer’s suggested protocol.  The samples were 
maintained in a -20°C freezer.  
Restriction Digest to verify insert 
 Restriction digests were performed with the Promega samples in order to verify 
for the synapsin insert.  The protocol for restriction digest involved 5µl DNA, EcoR1 
NEB Buffer, 1/10 BSA, Enzyme (EcoR1, Not1, Xho1, and Kpn1), and distilled water.  
The samples were incubated at 1 hour in a 37°C water bath before verifying products on a 
0.8% agarose gel. 
Polymerase Chain Reaction (PCR) to amplify Drosophila synapsin C-domain 
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a. PCR Amplification  
Primers were developed to amplify the Drosophila synapsin C-domain 
(dSynapsin).  The forward primer sequence of: 
GAATTCAAGTACTTCACGCTGCTGG and reverse primer sequence of: 
CTCGAGTTAACGGCAGACGTTCTGCATC were used.  The primers were 
used in the Polymerase Chain Reaction (PCR) to amplify the DNA and to allow 
for subcloning into pBluescript KS+.   
b. PCR Conditions and Cycling Parameters 
The PCR amplification was performed in a 50 µl reaction containing: 2 µl 
primer mix, 1 µl 1/1000 DNA, 4 µl 25µM MgCl2, 1 µl DNTP, 5 µl PCR buffer, 
36.5 µl dH20, and 0.5 µl Taq polymerase.  
The standard PCR cycling protocol was as follows: 94°C for 3 minutes; 5 
cycles of 94°C for 1 minute, 65°C for 1 minute, 72°C for 2 minutes; 5 cycles of 
94°C for 1 minute, 60°C for 1 minute, 72°C for 2 minutes; 30 cycles of 94°C for 
1 minute, 55°C for 1 minute, 72°C for 2 minutes; 72°C for 7 minutes; and 4°C 
until samples were retrieved.   
c. PCR Protocol for Subsequent Amplifications 
Subsequent PCR amplifications varied in the DNA concentration, cycling 
parameters and techniques, and the use of a linear sample of the dSynapsin.  
Concentrations varied to using 1/100, 1/50, 1/25 and 1/10 DNA. Cycling 
parameters and techniques involved a hot start technique, waiting for the lid to 
heat up prior to use. The cycling procedure was altered to 94°C for 3 minutes; 5 
cycles of 94°C for 1 minute, 65°C for 1 minute, 72°C for 2 minutes; 30 cycles of 
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94°C for 1 minute, 55°C for 1 minute, 72°C for 2 minutes; 72°C for 7 minutes; 
and 4°C until samples were retrieved.   
d. Verification of PCR Products  
Agarose Gel Electrophoresis: All PCR products were resolved on a 0.8% 
agarose gel and contained 3µl of Ethidium Bromide.  The samples were loaded 
with BBXF loading dye. 
Sequencing of dSynapsin samples 
 The samples obtained from the miniprep protocol were sequenced at the Nevada 
Genomics Center. Four sequencing primers were utilized in the sequencing of the 
dSynapsin. The machine used for sequencing at the genomics center was the Applied 
Biosystems Prism 3730 DNA Analyzer. A summary of the primers used is shown in 
Table 1. Sequencing was also performed with SynUp1, SynUp2, SynDown3, and 














Linearization of PCR Template 
A dSynapsin sample was digested with Not1 for 1 hour in a 37°C water bath. The 
samples were then run on a 0.8% low-melt agarose gel. The products were removed from 
the TAE agarose gel and purified using a Geneclean Kit (MP Biomedicals; Solon, OH) 
following the suggested protocol to purify DNA from TAE agarose gels. The purified 
product was then frozen in the -20°C freezer for future use.  
The purified geneclean sample was to test for amplification of the synapsin C-
domain. Primer sets were ordered to amplify outside of the anticipated area with forward 
Table 1. Summary of Primers Used for PCR and Sequencing  
Name of Primer 5' to 3' Sequence Use 
forwardEcoR1dSyn CGAATTCAAGTACTTCACGCTGCTGG PCR 
reverseXho1StopdSyn GCTCGAGTTAACGGCAGACGTTCTGCATC PCR 
SynUp1 CGGCCCATCCAAGATCAGC Sequencing 
SynUp2 CTGCGGTTCAGAGCGCCACACAAC Sequencing 
SynDown3 CCGAGGAGCGGGAGGGCAACTT Sequencing 
SynDown4 CGCTGCTCGTCTCGCTGGCCG Sequencing 
SynPCR2/Forward TCTTCCGAGGTAGACGATGTCGAT PCR 
SynPCR2/Reverse TCTGCCGCGCTTCTTATTAGCGAT PCR 
forwardAMPr TGACGCTCAGTGGAACGAAA PCR 
reverseAMPr GAGTATTCAACATTTCCGTGTCGC PCR 
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primer: SynPCR2/Forward and reverse primer: SynPCR2/Reverse.  PCR amplification of 
the ampicillin resistant portion was performed as a positive control.   
Preparation of pBluescript KS+ and pGex-6p-1 
 DH5α cells were transformed with pBluescript and pGex-6p-1.  After plating on 
LB-amp plates, the colonies were selected for purification using a Bio-Rad Plasmid 
Midiprep Kit (Bio-Rad; Hercules, CA) according to the manufacturer’s suggested 
protocol.  To verify the DNA samples, a restriction digest was performed using EcoRI 
(NEB), XhoI, and both for a double digest. The samples were digested for 1 hour in a 





Cloning and Transformation 
A clone of Drosophila Synapsin was ordered from the Drosophila Genomics 
Resource Center.  The dSynapsin was transformed into the pFLC1 vector thus indicating 
a full size of about 8.8 kb.  
The clones were verified by restriction digest.  The expected cut sites are shown 
in Figure 2 with enzymes EcoR1 and Xho1. Figure 3 shows the Promega samples as they 
were digested with enzymes EcoRI, XhoI, and both to test for inserts in the pFLC1 
vector. Three bands are expected to be shown by the digestion with EcoR1 at the sites 
shown in lane 2 with cut sites at 3.5kb, 4.9kb, and 5.3kb. Approximate sizes are 7kb, 1kb, 
and 404bp. Digestion with Xho1 should yield two cut sites at approximately 167bp and 
5.3kb.  Approximate sizes are 3kb and 5kb.  Lane 4 corresponds to the double digestion 
performed with both EcoR1 and Xho1 yielding a cut site at 4kb.  Lanes 1 and 5-12 




Figure 2. Restriction Map of dSynapsin and pFLC1 vector (8.8kb) 
 This figure shows the map of the dSynapsin in the pFLC1 vector 





Figure 3. Restriction digests of dSynapsin and purified dSynapsin on a 
0.8% agarose gel 
 This figure shows the miniprep samples from the dSynapsin as 
well as sample 1 digested with EcoR1, Xho1, and double digested with 
EcoR1 and Xho1. MW: molecular weight marker, 1kb ladder, lane 1 
shows sample 1, lane 2 shows dSynapsin digested with EcoR1, lane 3 
shows sample digested with Xho1, lane 4 shows sample double digested 




A second digestion was done to verify the insert.  Samples were digested with 
EcoRI, XhoI, NotI, and KpnI to test for inserts as an alternative to verifying the 
dSynapsin insert in pFLC1 vector.  Figure 4 represents the results obtained from the 
digestion with these enzymes.  Lane 1 shows the dSynapsin sample 2 used for this 
digestion. Lane 2 shows the digestion with Not1 which is not expected to make any cuts 
  MW    1      2     3     4       5     6     7      8        9    10    11   12 
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compared to the original sample in lane 1.  Lane 3 shows the digestion performed with 
Kpn1 with a single cut. Lane 4 shows digestion with EcoR1 with 3 cuts as previously 
performed. Lane 5 shows digestion with Xho1 and lane 6 shows dSynapsin sample 
number 10.   
 
Figure 4. Restriction digests of dSynapsin and dSynapsin on a 0.8% 
agarose gel 
 This figure shows the miniprep samples from the dSynapsin as 
well as sample 2 digested with Not1, Kpn1, EcoR1 and Xho1. Lane 1 
shows sample 2, lane 2 shows dSynapsin digested with Not1, lane 3 shows 
dSynapsin digested with Kpn1, lane 4 shows dSynapsin digested with 
EcoR1, lane 5 shows dSynapsin digested with Xho1 and lane 6 shows 
dSyapsin sample 10. 
 
 
  MW    1      2        3         4        5        6      
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Polymerase Chain Reaction (PCR) to amplify Drosophila synapsin C-domain 
PCR reactions were performed in an attempt to amplify the Drosophila synapsin 1 
C-domain.  Primers used are shown in Table 1.  These were designed to yield a C-domain 
flanked by EcoR1 and Xho1 creating sites for cloning.  There was also a stop codon 
inserted in-frame.  This was designed to clone into pGex-6p-1 to create an in-frame 
fusion protein with GST.  Conditions were changed for each new PCR reaction with 
varying concentrations of DNA, DNA samples, cycling parameters, primers and the use 
of a linear sample of the dSynapsin, as previously mentioned in the Methods section. No 
product was obtained by the methods used. As shown in figure 5, an expected band size 
would have been at about 950 kb.  Instead, only primers were observed. The primers 
were used for multiple reactions to confirm its action in differing PCR conditions.  
However, the expected product was not recovered upon verification of the PCR products.   
Figure 5 represents the general result of PCR reactions upon agarose gel 
electrophoresis for verification of the amplification of the C-domain.   The boxed region 
shown in the figure represents the expected size of the PCR product at 950 kb.  Lanes 1 
and 2 represent the DNA samples as different conditions were varied.  Lane 3 represents 
the negative control resulting in the primers, as shown.   
PCR reactions were performed using the forward and reverse primers: 
forwardEcoR1dSyn and reverseXho1StopdSyn by varying the Promega samples’ 
concentrations to 1/1000, 1/500, and 1/100. Concentrations of PCR mix for the protocol 
was also verified to confirm concentrations. The cycling parameters were altered to check 
for variation in its effect on yielding the expected PCR product.   
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An attempt was made to PCR amplify from another template.  A GM library 
sample graciously donated by Dr. Chi-Yun Pai (Department of Biology at the University 
of Nevada, Reno) was used for another PCR reaction.  The GM library was from the 
Berkeley Drosophila Genome Project.  The sample was an ovary oligo-dT phage library.  
A 1/1000 dilution was made of the provided sample then run according to the standard 
PCR protocol.  The expected product was not obtained.  The recovery only showed 
primers as verified by the control shown in lane 3.  
It was possible that the PCR primers ordered were not good for the reaction.  
Therefore, another PCR reaction was performed with primers that flanked the desired 
region: SynPCR2/Forward and SynPCR2/Reverse.  However, this again did not result in 










Figure 5. PCR products and negative control on a 0.8% agarose gel 
This figure shows the products of a PCR reaction with 1/1000 
DNA and 1/100 DNA.  A negative no template control was also used for 
this reaction. Lane 1 shows a molecular marker, lanes 2 and 3 show the 
DNA sample with no product yielded, and lane 4 shows the negative 
control. 
   
Sequencing of dSynapsin samples  
Another possible explanation for the failure to PCR amplify the clone was that the 
PCR primers did not match the sequence exactly. To verify the DNA sequence of the 
       MW         1            2             3 
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template, sequencing was performed with the sequencing primers mentioned in Table 1.  
Sequencing results from the Promega sample 7 with sequencing primer SynUp2 yielded 
the result shown in figure 6 as an NCBI Blast.  The result yielded approximately 240 base 
pairs. There was a 99% alignment with Drosophila synapsin and the query and subject 
lines indicate the match between the samples used in the lab against that in the NCBI 
library for confirmation of homology.  The highlighted portion indicates the homology of 
primer sequence previously used upstream of the AAG site in the C-domain.  Other 
sequences verified the presence of the other primers. 
 
Figure 6. Sequence alignment of dSynapsin with NCBI library Drosophila 
synapsin 
 This figure shows the NCBI library of Drosophila synapsin with 
the sequencing results of dSynapsin sample 7 sequenced with primer 
SynUp2. The sequences aligned at 99% confirming that the dSynapsin 




Geneclean: to linearize plasmid DNA 
A final possibility was that the DNA had a conformation that would not allow 
amplification. Therefore, linearization of the plasmid DNA was performed in hopes of 
being able to amplify the synapsin C-domain. Figure 7 shows the results of the agarose 
gel to confirm that the samples were prepared properly and as anticipated with a band at 
about 5kb shown in the boxed region of the gel.  
 
Figure 7.  Geneclean samples of dSynapsin on a 0.8% agarose gel 
 This figure shows the samples as a result of the geneclean 
procedure of the dSynapsin. Lane 1 shows the molecular weight and lanes 
2-3 show the Not1 digested samples indicating a band at 5kb.  
 
The geneclean product was then run in a PCR reaction.  An additional control 
reaction was done using primers to amplify the AMP resistance gene from the vector for 
MW      1        2 
17 
 
a positive control to verify accuracy of the PCR protocol.  Lanes 1-4 show the sample 
with previously used primer sets forwardEcoR1, reverseXho1, SynPCR2/Forward, and 
SynPCR2/Reverse. Lanes 5 and 6 represent the negative controls for each primer set. 
Lanes 1-6 did not yield the expected product size of 950kb. Lane 7 represents the primer 
set for ampicillin resistance indicating that the positive control was successful as shown 
in the boxed region on the agarose gel below at about 800bp.  
 
Figure 8. PCR products, negative control, and positive AMPr control on a 
0.8% agarose gel 
 This figure shows the molecular weight, the geneclean samples run 
with the primer sets in Table 1 for forward and reverse on lanes 1-4, lanes 
5-6 represent the negative control for the primer sets, and lane 7 represents 
the primer set for ampicillin resistance indicating a successful positive 
control for verification of the PCR protocol. However, no expected 
product was recovered.  
 
 





The overall goal of the project was to analyze the ATP binding and turnover in 
Drosophila synapsin. However, the amplification of the synapsin C-domain has been a 
big obstacle in proceeding with the anticipated goals of the project. Therefore, the 
question raised by information involving figure 1 was inconclusive in this study.  The 
first clones received from the Drosophila Genomics Resource Center did not yield 
enough cells. Few colonies had grown; this indicated that the cells used to transform the 
clones may not have been competent enough. Clones were reordered from the Drosophila 
Genomics Resource Center. Clones were successfully grown and the samples were 
purified using a miniprep protocol. The use of LB + carbenicillin plates instead of LB + 
ampicillin plates in transformation aided in yielding more colonies than the original 
transformation as the carbenicillin is less toxic to the bacteria resulting in a better yield. 
Figure 2 shows the confirmation of the samples for further use in the amplification of the 
synapsin C-domain. The dSynapsin samples from the DGRC were inserted into the 
pFLC1.  
PCR amplification was a difficult process in attempting to obtain the synapsin C-
domain. A sample of cDNA library of the synapsin from an ovary oligo-dT sample was 
graciously sent by Dr. Pai (Department of Biology; University of Nevada, Reno) for 
more PCR amplification.  
The PCR protocol was subsequently performed using the dSynapsin miniprep 
samples. Various conditions were altered each time in an attempt for amplification. The 
changes involved those mentioned in the methods. The alternations did not successfully 
yield a product.  Primers were ordered outside of the originally ordered primer set in 
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order to amplify a larger segment in hopes of using that piece to amplify the smaller 
segment. Although the sequencing primers confirmed a 100% homology to Drosophila 
synapsin, the PCR amplification was again unsuccessful.  
A Geneclean protocol was employed to linearize the plasmid DNA. This was 
done to overcome the circular structure or any super-secondary structures that may have 
been inhibiting the PCR amplification. Figure 7 shows the successful result of the 
Geneclean protocol of the dSynapsin. Again, the procedure was not an effective change 
in accordance to the reactions performed thus far.  However, as shown in figure 8, the 
positive control with the ampicillin portion yielded positive results indicating that the 
PCR protocol conditions were able to yield a product.  The expected band at 950kb was 
not recovered through this final process using the Geneclean product.   
Previous research on synapsin has had difficulty involving the cloning of the 
synapsin protein as well. In Klagges’ research on invertebrate synapsins, their study 
findings enabled them to clone a 50% identity gene with 309 amino acids. However, none 
of the cDNAs isolated were full-length (Klagges). Research by Hosaka has suggested that 
the molecular structure of synapsin is complex, enhancing the difficulties of PCR 
amplification of specific domains (Hosaka). Past research in the Mastick lab has also 
indicated that the synapsin protein is difficult to PCR amplify of specific regions 
(Mastick). 
Future directions of this project would be to finish amplifying the synapsin C-
domain. Upon doing so, the methods should continue with expression into GST fusion 
proteins for analysis of the ATP on and off rates to better understand its activity. The 
completion of this experiment will greatly benefit the characterization of the Drosophila 
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synapsin 1 C-domain.  This will be of great benefit to the scientific research and clinical 
community as it brings forth beneficial information regarding synapsin’s activity and 
how it can affect patients with epileptic symptoms. A better understanding of the 
synapsin C-domain can help draw relations to effects in humans and can enable studies of 
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